Mexolan (Meloxicam)

Meloxicam works by selectively blocking the cyclooxygenase‑2 (COX‑2) enzyme, which reduces the production of prostaglandins—chemical mediators that cause inflammation, pain, and fever. This selective inhibition helps control symptoms while preserving COX‑1 activity that protects the stomach lining.

The exact dose of Mexolan is determined by the prescribing clinician based on the patient’s condition, weight, renal function, and response to therapy. Healthcare professionals adjust the amount and frequency to achieve optimal pain control while minimizing risk.

Safety of meloxicam in pregnancy and lactation has not been established. It is generally avoided unless the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To order Mexolan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and necessary import documentation.

Compared with non‑selective NSAIDs, meloxicam offers greater COX‑2 selectivity, which may lower the incidence of gastrointestinal irritation while still providing strong anti‑inflammatory and analgesic effects. However, cardiovascular and renal risks remain similar to other NSAIDs, so patient‑specific factors guide drug choice.

Mexolan should be stored at ambient temperature, below 25 °C, in its original container to protect it from moisture and light. Do not freeze the product. Keep it out of reach of children and handle using standard aseptic techniques for injectable medicines.

Mexolan is given by intramuscular injection, typically into a large muscle such as the gluteus maximus. The injection should be performed by a qualified healthcare professional using aseptic technique, and the dose is administered according to the prescriber’s instructions.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, and severe skin reactions like Stevens‑Johnson syndrome. Patients should be monitored for signs of abdominal pain, chest discomfort, sudden weakness, or rash, and seek immediate medical attention if these occur.

Mexolan is contraindicated in patients with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal bleeding or ulceration, severe heart failure, and in the third trimester of pregnancy. Caution is also advised for individuals with impaired renal or hepatic function.